AMIE WUNDER: Open Payments
NPI 1629645551 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,080 in 123 payments from 12 companies in 2025. Trend: 2023 $1,786 · 2024 $1,639 · 2025 $2,080
Food & beverage: $2,080
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 19 | $460 |
| Vanda Pharmaceuticals Inc. | 25 | $364 |
| Otsuka America Pharmaceutical, Inc. | 15 | $288 |
| Teva Pharmaceuticals USA, Inc. | 28 | $241 |
| Alkermes, Inc. | 16 | $239 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $199 |
| Lundbeck LLC | 6 | $149 |
| ABBVIE INC. | 4 | $72 |
| Luye Pharma (USA) Ltd. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: HETLIOZ, REXULTI, COBENFY, ARISTADA, CAPLYTA, AUSTEDO XR, ABILIFY MAINTENA, VRAYLAR.
Industry payments across KS — which companies pay providers there.
